Adipose Tissue-Derived Multi-lineage Progenitor Cells as a Promising Tool for In Situ Stem Cell Therapy

2012 ◽  
Vol 1 (1) ◽  
pp. 54-62 ◽  
Author(s):  
Hanayuki Okura ◽  
Ayami Saga ◽  
Mayumi Soeda ◽  
Akihiro Ichinose ◽  
Akifumi Matsuyama
Keyword(s):  
Adipose Tissue ◽  
Stem Cell ◽  
Cell Therapy ◽  
Progenitor Cells ◽  
Stem Cell Therapy ◽  
Promising Tool

scholarly journals Adipose tissue-derived stem cell therapy in rat cryopreserved ovarian grafts

2015 ◽  
Vol 6 (1) ◽  
Author(s):  
Luciana Lamarão Damous ◽  
Juliana Sanajotti Nakamuta ◽  
Ana Elisa Teófilo Saturi de Carvalho ◽  
José Maria Soares-Jr ◽  
Manuel de Jesus Simões ◽  
...  
Keyword(s):  
Adipose Tissue ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy

scholarly journals Improving stem cell therapy in cardiovascular diseases: the potential role of microRNA

2016 ◽  
Vol 311 (1) ◽  
pp. H207-H218 ◽  
Author(s):  
Evelien Nollet ◽  
Vicky Y. Hoymans ◽  
Amaryllis H. Van Craenenbroeck ◽  
Christiaan J. Vrints ◽  
Emeline M. Van Craenenbroeck
Keyword(s):  
Bone Marrow ◽  
Stem Cell ◽  
Cardiovascular Diseases ◽  
Cell Therapy ◽  
Progenitor Cells ◽  
Stem Cell Therapy ◽  
Cell Function ◽  
Current Evidence ◽  
Comprehensive Overview ◽  
Vascular Regeneration

The initial promising prospect of autologous bone marrow-derived stem cell therapy in the setting of cardiovascular diseases has been overshadowed by functional shortcomings of the stem cell product. As powerful epigenetic regulators of (stem) cell function, microRNAs are valuable targets for novel therapeutic strategies. Indeed, modulation of specific miRNA expression could contribute to improved therapeutic efficacy of stem cell therapy. First, this review elaborates on the functional relevance of miRNA dysregulation in bone marrow-derived progenitor cells in different cardiovascular diseases. Next, we provide a comprehensive overview of the current evidence on the effect of specific miRNA modulation in several types of progenitor cells on cardiac and/or vascular regeneration. By elaborating on the cardioprotective regulation of progenitor cells on cardiac miRNAs, more insight in the underlying mechanisms of stem cell therapy is provided. Finally, some considerations are made regarding the potential of circulating miRNAs as regulators of the miRNA signature of progenitor cells in cardiovascular diseases.

scholarly journals Familial Occurrence of Pulmonary Embolism after Intravenous, Adipose Tissue-Derived Stem Cell Therapy

2013 ◽  
Vol 54 (5) ◽  
pp. 1293 ◽  
Author(s):  
Jae Woo Jung ◽  
Minsuk Kwon ◽  
Jae Chol Choi ◽  
Jong Wook Shin ◽  
In Won Park ◽  
...  
Keyword(s):  
Pulmonary Embolism ◽  
Adipose Tissue ◽  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Familial Occurrence

scholarly journals Mesenchymal Stem Cell Therapy Stimulates Endogenous Host Progenitor Cells to Improve Colonic Epithelial Regeneration

PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e70170 ◽  
Author(s):  
Alexandra Sémont ◽  
Christelle Demarquay ◽  
Raphaëlle Bessout ◽  
Christelle Durand ◽  
Marc Benderitter ◽  
...  
Keyword(s):  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Cell Therapy ◽  
Progenitor Cells ◽  
Stem Cell Therapy ◽  
Mesenchymal Stem Cell Therapy ◽  
Epithelial Regeneration

In situ stem cell therapy: novel targets, familiar challenges

2005 ◽  
Vol 23 (2) ◽  
pp. 78-83 ◽  
Author(s):  
Smita Agrawal ◽  
David V. Schaffer
Keyword(s):  
Stem Cell ◽  
Cell Therapy ◽  
Stem Cell Therapy ◽  
Novel Targets
Sign in / Sign up

Export Citation Format

Share Document